Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk
文献类型：期刊论文
| 作者 | He, Chiyu1; Qian, Yu2; Liu, Bin2; Yang, Shaoxue3; Ye, Ding2; Sun, Xiaohui2; Chen, Tianhui4; Mao, Yingying2 |
| 刊名 | FRONTIERS IN ONCOLOGY
 |
| 出版日期 | 2020-10-14 |
| 卷号 | 10 |
| ISSN号 | 2234-943X |
| 关键词 | C-reactive protein genome-wide association study Mendelian randomization prostate cancer single-nucleotide polymorphisms |
| DOI | 10.3389/fonc.2020.545603 |
| 通讯作者 | Chen, Tianhui(chenth@zjcc.org.cn) ; Mao, Yingying(myy@zcmu.edu.cn) |
| 英文摘要 | Background: Inconsistent findings from observational studies have reported that C-reactive protein (CRP) is likely associated with risk of prostate cancer. Because conventional observational studies are susceptible to confounding and reverse causality, it remains unclear whether there is a causal relationship of CRP with risk of prostate cancer. Methods: In this study, we applied a two-sample Mendelian randomization (MR) approach to evaluate the potential causal association of circulating CRP levels with prostate cancer risk. Instrumental variables (IVs) and corresponding genetic association estimates for circulating CRP levels were obtained from a meta-analysis of genome-wide association studies (GWASs) including 204,402 participants of European descent. The genetic association estimates of these IVs with prostate cancer were obtained from a GWAS meta-analysis including 79,148 cases and 61,106 controls of European ancestry. The inverse-variance weighted (IVW) method was used as primary MR analyses, whereas in sensitivity analyses, MR-Egger regression, and MR pleiotropy residual sum and outlier (MR-PRESSO) test were used to assess the presence of pleiotropy. Odd ratio (OR) and 95% CI were calculated. Results: Overall, 58 single-nucleotide polymorphisms were used as instruments for circulating CRP levels. MR analysis suggested that genetically determined CRP levels were not associated with prostate cancer risk (OR 1.06, 95% CI 0.96 to 1.16) using the IVW method. Sensitivity analyses using alternative MR methods produced similar results (OR 1.00, 95% CI 0.93 to 1.08 for the weighted-median method; OR 1.02, 95% CI 0.95 to 1.08 for MR-PRESSO test). MR-Egger regression did not suggest evidence of directional pleiotropy (P = 0.25). Conclusion: Our study found that genetically predicted circulating CRP levels were not associated with prostate cancer risk, suggesting that CRP is unlikely to be a causal factor in the development of prostate cancer. |
| WOS关键词 | MENDELIAN RANDOMIZATION ; INFLAMMATORY MARKERS ; INSTRUMENTS ; INTERLEUKIN-6 ; PREVENTION ; HEALTH ; BIAS |
| 资助项目 | National Natural Science Foundation of China[81973663] ; National Natural Science Foundation of China[81602917] ; Natural Science Foundation of Zhejiang Province[LQ20H260008] ; Talent Project of Zhejiang Association for Science and Technology[2018YCGC003] ; Foundation of Zhejiang Chinese Medical University[KC201905] ; Foundation of Zhejiang Chinese Medical University[2020ZR09] ; Startup Funds for Recruited Talents at Zhejiang Cancer Hospital |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | FRONTIERS MEDIA SA |
| WOS记录号 | WOS:000584419500001 |
| 资助机构 | National Natural Science Foundation of China ; Natural Science Foundation of Zhejiang Province ; Talent Project of Zhejiang Association for Science and Technology ; Foundation of Zhejiang Chinese Medical University ; Startup Funds for Recruited Talents at Zhejiang Cancer Hospital |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/105085]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Chen, Tianhui; Mao, Yingying |
| 作者单位 | 1.Zhejiang Chinese Med Univ, Coll Clin Med 2, Hangzhou, Peoples R China 2.Zhejiang Chinese Med Univ, Sch Basic Med Sci, Hangzhou, Peoples R China 3.Chinese Acad Sci, Inst Basic Med & Canc IBMC, Zhejiang Canc Hosp, Univ Chinese Acad Sci,Dept Clin Lab,Canc Hosp, Hangzhou, Peoples R China 4.Chinese Acad Sci, Inst Basic Med & Canc IBMC, Zhejiang Canc Hosp, Univ Chinese Acad Sci,Canc Hosp,Dept Canc Prevent, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | He, Chiyu,Qian, Yu,Liu, Bin,et al. Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk[J]. FRONTIERS IN ONCOLOGY,2020,10. |
| APA | He, Chiyu.,Qian, Yu.,Liu, Bin.,Yang, Shaoxue.,Ye, Ding.,...&Mao, Yingying.(2020).Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk.FRONTIERS IN ONCOLOGY,10. |
| MLA | He, Chiyu,et al."Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk".FRONTIERS IN ONCOLOGY 10(2020). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。